FDA clears PM’s Zyn to market as lower cancer risk than cigarettes in 20 variants

Investing.com Gold reports: FDA clears PM’s Zyn to market as lower cancer risk than cigarettes in 20 variants. Full body text was unavailable at ingest time, so this brief is based on headline context.